RSPH Invesco S&P 500 Equal Weight Health Care ETF
Quote as of Aug 26, 2026 20:00 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Previous Close | 38.02 | Day Range | 37.73 – 37.97 |
| 52-Week Range | 28.26 – 38.19 | Volume | 67.98K |
| Avg Volume | 135.51K | AUM | $838.6M (Aug 27, 2026) |
| Expense Ratio | 0.40% | Yield (TTM) | 0.61% |
| NAV | 38.00 | Premium/Discount | -0.42% indicative |
| Inception | Nov 01, 2006 | Holdings | 60 |
| Issuer | Invesco | Exchange | AMEX |
| Category | Healthcare | Index Tracked | S&P 500 |
| CUSIP | 46137V332 | ISIN | US46137V3327 |
| Management | Passive / index-tracking (per issuer description) | ||
About this ETF
The Invesco S&P 500 Equal Weight Health Care ETF aims to track the performance of the S&P 500 Equal Weight Health Care Index. This fund primarily allocates a minimum of 90% of its total assets to the common stocks that constitute its underlying benchmark. The Index itself assigns an equal weighting to all healthcare sector companies that are part of the broader S&P 500 Index. Both the ETF and the Index undergo a portfolio adjustment process on a quarterly basis.
Description from the fund data provider · profile as of Aug 27, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | +10.87% | +23.02% | +15.02% | +18.81% | +28.66% | +9.48% | +3.85% | +9.25% | +10.71% |
| Total return | +10.87% | +23.26% | +15.44% | +19.26% | +29.59% | +10.25% | +4.57% | +9.91% | +11.35% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Aug 26, 2026. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.40% | Annual cost of a $10,000 investment | $40.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Aug 26, 2026 — portfolio reporting date from the data provider; holdings are not live positions. 64 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | Moderna Inc | MRNA | 4.89% | 258.49K | $41.1M |
| 2 | Charles River Laboratories International Inc | CRL | 2.26% | 63.80K | $19.0M |
| 3 | Veeva Systems Inc | VEEV | 2.14% | 72.58K | $17.9M |
| 4 | IQVIA Holdings Inc | IQV | 2.02% | 65.30K | $16.9M |
| 5 | Regeneron Pharmaceuticals Inc | REGN | 1.96% | 19.76K | $16.5M |
| 6 | Bio-Techne Corp | TECH | 1.95% | 226.39K | $16.4M |
| 7 | Merck & Co Inc | MRK | 1.86% | 99.74K | $15.6M |
| 8 | Amgen Inc | AMGN | 1.86% | 35.19K | $15.6M |
| 9 | Thermo Fisher Scientific Inc | TMO | 1.85% | 24.66K | $15.5M |
| 10 | Abbott Laboratories | ABT | 1.85% | 133.36K | $15.5M |
| 11 | Baxter International Inc | BAX | 1.83% | 585.00K | $15.4M |
| 12 | Becton Dickinson & Co | BDXA | 1.82% | 80.43K | $15.3M |
| 13 | Vertex Pharmaceuticals Inc | VRTX | 1.80% | 27.28K | $15.1M |
| 14 | Labcorp Holdings Inc | LH | 1.78% | 44.22K | $14.9M |
| 15 | Mettler-Toledo International Inc | MTD | 1.76% | 10.53K | $14.8M |
| 16 | Revvity Inc | PKI | 1.75% | 117.28K | $14.6M |
| 17 | Incyte Corp | INCY | 1.74% | 112.73K | $14.6M |
| 18 | Gilead Sciences Inc | GILD | 1.73% | 97.75K | $14.5M |
| 19 | ResMed Inc | RMD | 1.73% | 61.41K | $14.5M |
| 20 | Bristol-Myers Squibb Co | BMY | 1.73% | 213.73K | $14.5M |
| 21 | Universal Health Services Inc | UHS | 1.72% | 82.02K | $14.4M |
| 22 | Quest Diagnostics Inc | DGX | 1.70% | 58.34K | $14.3M |
| 23 | Dexcom Inc | DXCM | 1.69% | 158.91K | $14.2M |
| 24 | AbbVie Inc | ABBV | 1.67% | 52.83K | $14.0M |
| 25 | Danaher Corp | DHR | 1.67% | 64.75K | $14.0M |
Click a ticker to see every ETF that owns it.
Sector Exposure
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | 0.61% | Paid (last 12 months) | $0.2317 |
| Frequency | Quarterly | SEC yield | Not provided by our data source — see the issuer page |
| Last ex-date | Jun 22, 2026 | Last payment | $0.0627 (Jun 26, 2026) |
| Growth 1Y | +4.31% | Growth 3Y / 5Y (ann.) | -49.91% / -28.59% |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Jun 22, 2026 | Jun 22, 2026 | Jun 26, 2026 | $0.0627 |
| Mar 23, 2026 | Mar 23, 2026 | Mar 27, 2026 | $0.0561 |
| Dec 22, 2025 | Dec 22, 2025 | Dec 26, 2025 | $0.0530 |
| Sep 22, 2025 | Sep 22, 2025 | Sep 26, 2025 | $0.0599 |
| Jun 23, 2025 | Jun 23, 2025 | Jun 27, 2025 | $0.0555 |
| Mar 24, 2025 | Mar 24, 2025 | Mar 28, 2025 | $0.0551 |
| Dec 23, 2024 | Dec 23, 2024 | Dec 27, 2024 | $0.0569 |
| Sep 23, 2024 | Sep 23, 2024 | Sep 27, 2024 | $0.0547 |
| Jun 24, 2024 | Jun 24, 2024 | Jun 28, 2024 | $0.0508 |
| Mar 18, 2024 | Mar 19, 2024 | Mar 22, 2024 | $0.0459 |
| Dec 18, 2023 | Dec 19, 2023 | Dec 22, 2023 | $0.0499 |
| Sep 18, 2023 | Sep 19, 2023 | Sep 22, 2023 | $0.0479 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
| Volatility 1Y / 3Y | 16.68% / 15.99% | Sharpe 1Y / 3Y | 1.67 / 0.502 |
| Max drawdown 1Y / 3Y | -10.89% / -17.12% | Sortino 1Y | 2.83 |
| Beta vs S&P 500 (3Y) | 0.586 | Correlation vs S&P 500 (1Y) | 0.356 |
| Downside deviation 1Y | 9.83% | Risk-free rate used | 3.71% (3M T-bill, FRED) |
Computed by ETF Explorer from daily dividend-adjusted closes; volatility and drawdown are annualized/period figures; S&P 500 exposure proxied by SPY. As of Aug 27, 2026. Formulas →
Liquidity
| Volume today | 67.98K | Average volume | 135.51K |
| AUM | $838.6M | Premium/Discount | -0.42% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV — an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Fund Flows (estimated)
| Period | Est. net flow | % of starting AUM | AUM start → end |
|---|---|---|---|
| 1 Day | $7.2M | +0.86% | $831.5M → $838.6M |
| 1 Week | $40.4M | +5.15% | $785.3M → $838.6M |
ETF Explorer estimate: change in reported AUM minus the market-move effect, from our own daily snapshots. Not official issuer creation/redemption data.
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source — review them before investing.
Latest News for RSPH
No articles mention this fund directly in the last 7 days — showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.